Skip to content

Effect of electrical stimulation in women with voiding dysfunction

Effects of Interferential Stimulation on Clinical Symptom and Urodynamic Findings in Women with Voiding Dysfunction: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180611040061N2
Enrollment
28
Registered
2024-11-12
Start date
2024-12-05
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Voiding dysfunction. Bladder-neck obstruction

Interventions

Intervention 1: Intervention group: Real interferential electrical stimulation with a carrier frequency of 4000 Hz and a beat frequency of 80-160 Hz using Novin device (2 channels/made in Iran, Isfaha
however in this group the intensity of the output of the device will be adjusted to the initial sensation of the patient and then after 1 minute, the output of the device will be turn off.

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Women between 18 and 65 years old Positive urodynamic criteria favor the voiding dysfunction diagnosis. Women who have voiding dysfunction according to urologist diagnosis. Women whose 3-day urinary history has an average visit to the bathroom more than 8 times in 24 hours. Absence of pregnancy and breastfeeding No history of spinal and pelvic surgery in the last 2 years No history of back and pelvic malignancies in the last 2 years Absence of structural disorder, neurological disorder, history of chronic disease Absence of neurologic bladder Absence of voiding dysfunction secondary to drug use or other diseases Absence of high degrees of pelvic organ prolapse (degrees higher than 2) Personal written consent to enter the study

Exclusion criteria

Exclusion criteria: Obvious infection or pathology in the pelvic area during the treatment process Impossibility of necessary patient cooperation in the treatment process Receiving other treatment at the same time during the sessions of the present study Failure to complete treatment sessions by the patient

Design outcomes

Primary

MeasureTime frame
Maximum urine flow(Qmax). Timepoint: Measurement of maximum urine flow before the start of the intervention, 2 weeks and 3 months after the end of the treatment sessions. Method of measurement: Uroflowmetry.;Lower urinary tract symptoms severity. Timepoint: Measurement of lower urinary tract symptoms severity 2 weeks after the end of the treatment sessions. Method of measurement: Persian version of international consultation on incontinence questionnaire – female lower urinary tract symptoms.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Saeideh Babazadeh

Iran University of Medical Sciences

babazadehpt89@gmail.com+98 21 2222 7124

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026